Correlation between hepatocyte and hepatic progenitor cell regeneration and model for end stage liver disease (MELD) score in acute severe liver impairment

被引：0
|
作者：
Katoonizadeh, A.
Nevens, F.
Verslype, C.
Pirenne, J.
Roskams, T.
机构：
[1] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Hepatol, Louvain, Belgium
[2] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Pathol, Louvain, Belgium
[3] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Abdominal Transplant Surg, Louvain, Belgium
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)61761-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
163
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [11] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [12] Improvements in the model for end-stage liver disease (MELD) severity score.
    Dykstra, DM
    Wiesner, RH
    Port, FK
    Wolfe, RA
    Merion, RM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 516 - 516
  • [13] Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
    Lau, Tsang
    Ahmad, Jawad
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2013, 5 : 1 - 10
  • [14] Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors
    Punch, Jeffrey
    Gish, Robert G.
    LIVER TRANSPLANTATION, 2006, 12 (12) : S122 - S123
  • [15] Model for End Stage Liver Disease (MELD) Score & ALT-LDH Index as Poor Prognostic Indicators in Acute Liver Failure
    Maheshwari, Prem Kumar
    Memon, Ehsan Rahim
    Lakho, Shabana
    Ul Haque, Zeeshan
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 985 - 988
  • [16] Outcomes for patients listed for liver transplantation with a low Model for End-Stage Liver Disease (MELD) score
    Mufti, Arjmand R.
    Tanriover, Bekir
    Singal, Amit G.
    Marrero, Jorge A.
    HEPATOLOGY, 2016, 64 : 697A - 698A
  • [17] Model for end-stage liver disease (MELD) for liver allocation: A 5-year score card
    Freeman, Richard B., Jr.
    HEPATOLOGY, 2008, 47 (03) : 1052 - 1057
  • [18] Model for end-stage liver disease (MELD) exception for polycystic liver disease
    Arrazola, Luis
    Moonka, Dilip
    Gish, Robert G.
    Everson, Gregory T.
    LIVER TRANSPLANTATION, 2006, 12 (12) : S110 - S111
  • [19] RELATIONSHIP BETWEEN MODEL FOR END-STAGE LIVER DISEASE EXCLUDING INR(MELD-XI) SCORE AND LIVER FIBROGENESIS MARKER IN ACUTE HEART FAILURE
    Aida, Kenji
    Nagao, Kazuya
    Kajitani, Kenji
    Kobayashi, Takayasu
    Tamura, Akinori
    Simamura, Kiyotaka
    Yukawa, Hiroshi
    Kobayashi, Yohei
    Takahashi, Naoki
    Nakagawa, Eiichiro
    Ito, Haruyasu
    Hayashi, Fujio
    Makita, Toshinori
    Inada, Tsukasa
    Tanaka, Masaru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 626 - 626
  • [20] Association of model for END-Stage liver disease (MELD) score with spontaneous bacterial peritonitis
    Obstein, Keith L.
    Campbell, Mical S.
    Reddy, K. Rajender
    Yang, Yu-Xiao
    GASTROENTEROLOGY, 2007, 132 (04) : A801 - A801
12345